Defibrotide TMA Prophylaxis Pilot Trial

NCT03384693 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Thrombotic Microangiopathies

Interventions

DRUG: Defibrotide

Sponsor

University of California, San Francisco